Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)

NCT07241715 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT07241715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07241715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)
Lead sponsor
National University Hospital, Singapore
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
February 21, 2026
Completion date
January 31, 2034
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer stage iv, peritoneal metastasis